Computational hybrid approach of PBPK simulation and CGCNN models for human intravenous pharmacokinetics
{{output}}
In drug discovery, it is not sufficient for a lead compound to exhibit high binding affinity for the target protein alone. It is equally important to predict an optimal pharmacokinetic (PK) profile that reflects the physicochemical properties of the compound. ... ...
